Delivery Order SPE2DB22D3501-SPE2DB24FWV06
Award Date
8/30/24
Potential Completion Date
9/3/24
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a value of $1,045.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566555611 - Norepinephrine 4 mg/4 ml vial, 4 ml, with a performance period ending on November 27, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,150.35, is for the delivery of Norepinephrine 8 mg/250 mL-D5W 250 mL. This is a firm fixed-price delivery order with an ultimate completion date of October 31, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,017,672 units of the drug Norepinephrine 8 mg/250 mL-D5W 250 mL. The contract has a ceiling value of $1,009.65 and is a firm fixed-price delivery order with a period of performance through January 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,714.94 firm fixed-price delivery order is for the supply of 4560983330 - Norepinephrine 4 mg/250 ml-D5W 250 ml, with a completion date of May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant...
This federal contract award, valued at $1,065.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Norepinephrine 4 mg/250 mL-D5W, a critical care medication, to support military treatment facilities and other government healthcare providers. This delivery order contract is a firm fixed-price agreement, with an ultimate completion date of August 13, 2024. Amerisourcebergen holds several...
This federal contract award, SPE2DX15D3012|SPE2DX24F8VJ5, was made by the U.S. Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,927.08 firm fixed-price delivery order is for the supply of 4,565,846,958 units of 4 mg/4 ml norepinephrine vials. The contract has no set-aside designation and an ultimate completion date of September 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,759.11, is for the delivery of a 250 mL bag of norepinephrine 8 mg/250 mL in D5W. This is a firm fixed-price delivery order contract with a completion date of January 23, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, with ID SPE2DB22D3501|SPE2DB23FVQ90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560896338 - Norepinephrine 8 mg/250 ml-D5W 250 ml, a pharmaceutical product. The contract has a ceiling value of $1,624.18 and is a Firm Fixed Price Delivery Order type, with a period of performance through May 11, 2023. This award is not associated with a set-aside designation,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,016.76, is for the delivery of a medical product, specifically 4563886967 ! NOREPINEPHRINE 8 MG/250 ML-D5W 250ML. The contract has a firm fixed price and an ultimate completion date of March 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of Norepinephrine 4 mg/4 ml vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,578.89, and has a completion date of May 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, worth up to...